Approval for a new trade name for the hp60m hydrogel iol.  The device, as modified, will be marketed under the trade name "meridian" and is indicated for primary implantation for the visual correction of aphakia in patients 60 years of age or older where a cataractous lens has been removed by extracapsular extraction methods.  The lens is designed for implantation in the capsular bag following extracapsular cataract extraction.